Literature DB >> 8417344

Estradiol-inducible squelching and cell growth arrest by a chimeric VP16-estrogen receptor expressed in Saccharomyces cerevisiae: suppression by an allele of PDR1.

D M Gilbert1, D M Heery, R Losson, P Chambon, Y Lemoine.   

Abstract

We have constructed and characterized a flexible system for analyzing the phenomenon of squelching and estrogen receptor function in the yeast Saccharomyces cerevisiae. The A/B region of the human estrogen receptor was replaced with the transcriptional activating domain of VP16 and expressed in yeast cells from high-copy-number plasmids. Addition of hormone resulted in an immediate inhibition of expression (squelching) of a chromosomally integrated GAL1:lacZ reporter gene and the eventual arrest of cell growth (toxicity). In order to determine whether a relationship exists between toxicity and squelching, mutations were made in this chimeric receptor (VEO) and their effects on transcriptional activation, squelching, and toxicity were compared. A direct correlation was found between mutations in VEO that reduced VP16 transactivation ability in yeast cells and those that reduced both squelching and toxicity. Surprisingly, mutations in the DNA binding domain (DBD) of VEO dramatically reduced squelching and completely relieved toxicity, suggesting a role for the DBD in squelching and strengthening the correlation between squelching and toxicity. To demonstrate the utility of this system for carrying out genetic selection, a plasmid-based yeast genomic bank was screened for genes that can relieve the toxicity of VEO by means of an elevated copy number, resulting in the repeated cloning of an allele of the PDR1 (pleiotropic drug resistance) gene. We present evidence that mutations in PDR1 can modulate the intracellular availability of estradiol by the same mechanism that leads to multiple drug resistance in yeast cells. Taken together, our results provide evidence that cell growth arrest occurs when squelching exceeds a certain threshold and that strong squelching requires both a DBD and a transcriptional activating domain. Furthermore, we show that growth arrest can provide a useful phenotype for carrying out the genetic analysis of both squelching and estrogen receptor function in yeast cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417344      PMCID: PMC358926          DOI: 10.1128/mcb.13.1.462-472.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  A versatile in vivo and in vitro eukaryotic expression vector for protein engineering.

Authors:  S Green; I Issemann; E Sheer
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

3.  The human oestrogen receptor functions in yeast.

Authors:  D Metzger; J H White; P Chambon
Journal:  Nature       Date:  1988-07-07       Impact factor: 49.962

4.  Functional domains of the human estrogen receptor.

Authors:  V Kumar; S Green; G Stack; M Berry; J R Jin; P Chambon
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

5.  A short amino acid sequence able to specify nuclear location.

Authors:  D Kalderon; B L Roberts; W D Richardson; A E Smith
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

6.  The multidrug resistance gene PDR1 from Saccharomyces cerevisiae.

Authors:  E Balzi; W Chen; S Ulaszewski; E Capieaux; A Goffeau
Journal:  J Biol Chem       Date:  1987-12-15       Impact factor: 5.157

7.  Transcriptional and translational expression of a chimeric bacterial-yeast plasmid in yeasts.

Authors:  M R Chevallier; J C Bloch; F Lacroute
Journal:  Gene       Date:  1980-10       Impact factor: 3.688

8.  Saccharomyces cerevisiae GAL1-GAL10 divergent promoter region: location and function of the upstream activating sequence UASG.

Authors:  R W West; R R Yocum; M Ptashne
Journal:  Mol Cell Biol       Date:  1984-11       Impact factor: 4.272

9.  Antagonistic controls regulate copy number of the yeast 2 mu plasmid.

Authors:  J A Murray; M Scarpa; N Rossi; G Cesareni
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

10.  Structural rearrangements of tubulin and actin during the cell cycle of the yeast Saccharomyces.

Authors:  J V Kilmartin; A E Adams
Journal:  J Cell Biol       Date:  1984-03       Impact factor: 10.539

View more
  16 in total

1.  Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential.

Authors:  U Baron; M Gossen; H Bujard
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

2.  Transient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes.

Authors:  Michael J Guertin; Xuesen Zhang; Scott A Coonrod; Gordon L Hager
Journal:  Mol Endocrinol       Date:  2014-07-22

3.  A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen.

Authors:  D Knutti; A Kaul; A Kralli
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

4.  Direct study of DNA-protein interactions in repressed and active chromatin in living cells.

Authors:  M P Kladde; M Xu; R T Simpson
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

5.  Targeting of promoters for trans activation by a carboxy-terminal domain of the NS-1 protein of the parvovirus minute virus of mice.

Authors:  D Legendre; J Rommelaere
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Inducible, tightly regulated and non-leaky neuronal gene expression in mice.

Authors:  Fabien Delerue; Michael White; Lars M Ittner
Journal:  Transgenic Res       Date:  2013-11-09       Impact factor: 2.788

7.  The mother enrichment program: a genetic system for facile replicative life span analysis in Saccharomyces cerevisiae.

Authors:  Derek L Lindstrom; Daniel E Gottschling
Journal:  Genetics       Date:  2009-08-03       Impact factor: 4.562

8.  Constitutive retinoid receptors expressed from adenovirus vectors that specifically activate chromosomal target genes required for differentiation of promyelocytic leukemia and teratocarcinoma cells.

Authors:  S M Lipkin; T L Grider; R A Heyman; C K Glass; F H Gage
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  PDR3, a new yeast regulatory gene, is homologous to PDR1 and controls the multidrug resistance phenomenon.

Authors:  T Delaveau; A Delahodde; E Carvajal; J Subik; C Jacq
Journal:  Mol Gen Genet       Date:  1994-09-01

10.  Single-chain Tet transregulators.

Authors:  Christel Krueger; Christian Berens; Andreas Schmidt; Dirk Schnappinger; Wolfgang Hillen
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.